comprehensive -WSS

comprehensive

author：Wikipedia 2025-09-27 19:01:58 - browse：57

Vir Biotechnology said Thursday that a long-acting antibody drug designed to protect healthy individuals from influenza A failed to do so in a nearly 3,000-person clinical trial.

Volunteers who received the highest dose of the drug, known as VIR-2482, were only 16% less likely than the placebo group to develop symptomatic influenza A infections, as defined by trial criteria, over a seven-month period. The difference was not statistically significant.

The results are a setback in broader efforts to develop better protective measures against both seasonal and potential pandemic influenza strains. In the short term, Vir and outside experts hoped VIR-2482 could provide additional annual protection for at-risk groups like older adults, as flu vaccines are often only modestly effective.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Readout Newsletter: The latest on Amylyx, Moderna, Novavax

explore

WSS

Pfizer is about to make a big push in cancer. Will investors listen?

Doctor of U.S. President Joe Biden says he is fit for duty

FDA official pushes for dedicated emerging pathogens team

CDC panel: People 65 and older should get a Covid spring booster shot

Covid overtakes 1918 Spanish flu as deadliest disease in U.S. history

Virtual repurposing can help discover new uses for existing drugs

hotspot

comprehensive

focus

DIEP, the 'gold standard' of breast reconstruction, is under threat

Organ transplantation is at a crossroads. Major reform is needed

Duchenne breakthrough therapy leaves behind pioneering families

Providers still hesitate to prescribe buprenorphine, study finds

Activists slam private health insurers over coverage restrictions

As Taiwan prepares for anti

How one medical school became remarkably diverse

Are embryos people? Reproductive medicine's future depends on the answer

Medicare proposal to cover medical devices draws a mixed reaction

Why an extreme heat and wildfire smoke combination can be so dangerous

focus

There should be a 'Moonshot' or 'Warp Speed' for rare diseases

Russian special forces kill a gunman who broke into a private house near Moscow

Southern California school board OKs curriculum after Gov. Gavin Newsom threatened a $1.5M fine

Organ transplantation is at a crossroads. Major reform is needed

Pfizer is about to make a big push in cancer. Will investors listen?

Doctor of U.S. President Joe Biden says he is fit for duty

explore

knowledge

explore

knowledge